BiotechTube
Home/Neuvogen/Christian Ottensmeier, MD, PhD, FRCP
CO

Christian Ottensmeier, MD, PhD, FRCP

Acting Chief Scientific Officer

Neuvogen

Therapeutic Areas

OncologySolid Tumors

Neuvogen Pipeline

DrugIndicationPhase
Undisclosed Whole Cell Vaccine Program(s)Solid TumorsPre-clinical

Leadership Team at Neuvogen

TB
Todd Binder, MBA
Chief Executive Officer
View full Neuvogen profile